Evidence map›Paper›PMID 26472872›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2016

Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise.

Pil-Ki Min, Joseph Park, Stephanie Isaacs, Beth A Taylor, Paul D Thompson, Chris Troyanos, Pierre D'Hemecourt, Sophia Dyer, Stephen Y Chan, Aaron L Baggish

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Non-coding RNAs in exercise immunology: A systematic review.Journal of sport and health science · 2024
    Pooled it
  2. Exosomes and microRNAs as mediators of the exercise.European journal of medical research · 2025
    Review
  3. Article
  4. Article
  5. Advances in laboratory medicine · 2023
    Article
  6. Article
  7. A microRNA Signature for the Diagnosis of Statins Intolerance.International journal of molecular sciences · 2022
    Article
  8. Review
  9. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Review
  12. Review
  13. Mechanisms of statin-induced new-onset diabetes.Journal of cellular physiology · 2019
    Review
  14. Review
  15. Article
  16. Management of Statin Intolerance in 2018: Still More Questions Than Answers.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2018
    Review
  17. Review
  18. Circulating MicroRNAs as Potential Biomarkers of Exercise Response.International journal of molecular sciences · 2016
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Pil-Ki MinBrigham and Women's Hospital, Division of Cardiovascular Medicine, Department of Medicine, Harvard Medical School, Boston, Massachusetts; Cardiology Division, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Joseph ParkBrigham and Women's Hospital, Division of Cardiovascular Medicine, Department of Medicine, Harvard Medical School, Boston, Massachusetts;
Stephanie IsaacsCardiovascular Performance Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts;
Beth A TaylorHenry Low Heart Center, Division of Cardiology, Hartford Hospital, Hartford, Connecticut;
Paul D ThompsonHenry Low Heart Center, Division of Cardiology, Hartford Hospital, Hartford, Connecticut;
Chris TroyanosBoston Athletic Association, Boston, Massachusetts; and.
Pierre D'HemecourtBoston Athletic Association, Boston, Massachusetts; and.
Sophia DyerBoston Athletic Association, Boston, Massachusetts; and.
Stephen Y ChanBrigham and Women's Hospital, Division of Cardiovascular Medicine, Department of Medicine, Harvard Medical School, Boston, Massachusetts; chansy@pitt.edu.
Aaron L BaggishCardiovascular Performance Program, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Boston Athletic Association, Boston, Massachusetts; and.
Harvard University · USBrigham and Women's Hospital · USHartford Hospital · US

Funding

Defining the Complex Biology of the miR-130/301 Family in Pulmonary HypertensionR01HL124021 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHAN, STEPHEN Y · 2014 to 2025
$4.9M
Iron-Sulfur Deficiency as a Critical Pathogenic Cause of Pulmonary HypertensionR01HL122596 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHAN, STEPHEN Y · 2015 to 2024
$4.5M
NHLBI NIH HHS R01 HL122596NHLBI NIH HHS R01 HL124021
6 · The paper itself

Abstract

Statins exacerbate exercise-induced skeletal muscle injury. Muscle-specific microRNAs (myomiRs) increase in plasma after prolonged exercise, but the patterns of myomiRs release after statin-associated muscle injury have not been examined. We examined the relationships between statin exposure, in vitro and in vivo muscle contraction, and expression of candidate circulating myomiRs. We measured plasma levels of myomiRs, circulating microRNA-1 (c-miR-1), c-miR-133a, c-miR-206, and c-miR-499-5p from 28 statin-using and 28 nonstatin-using runners before (PRE), immediately after (FINISH), and 24 h after they ran a 42-km footrace (the 2011 Boston marathon) (POST-24). To examine these cellular-regulation myomiRs, we used contracting mouse C2C12 myotubes in culture with and without statin exposure to compare intracellular and extracellular expression of these molecules. In marathoners, c-miR-1, c-miR-133a, and c-miR-206 increased at FINISH, returned to baseline at POST-24, and were unaffected by statin use. In contrast, c-miR-499-5p was unchanged at FINISH but increased at POST-24 among statin users compared with PRE and runners who did not take statins. In cultured C2C12 myotubes, extracellular c-miR-1, c-miR-133a, and c-miR-206 were significantly increased by muscle contraction regardless of statin use. In contrast, extracellular miR-499-5p was unaffected by either isolated statin exposure or isolated carbachol exposure but it was increased when muscle contraction was combined with statin exposure. In summary, we found that statin-potentiated muscle injury during exercise is accompanied by augmented extracellular release of miR-499-5p. Thus c-miR-499-5p may serve as a biomarker of statin-potentiated muscle damage.

Indexed as

AnimalsBiomarkersCells, CulturedExerciseFemaleHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMiceMicroRNAsMiddle AgedMuscle ContractionMuscle Fibers, SkeletalMuscle, SkeletalMuscular DiseasesPhysical EnduranceBiomarkersHydroxymethylglutaryl-CoA Reductase InhibitorsMicroRNAsexercisehydroxymethylglutaryl-CoA reductase inhibitorsmicroRNAsmuscle contractionskeletal muscle

Identifiers

PMID26472872
PMCPMC5504424
OpenAlexW2307460273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.